AngioDynamics Inc (ANGO) stock
ANGONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 8, 2026Score 12/3011% below fair value
$11.49−0.29 (-2.46%)
Close on Nov 17, 2026Market cap $483.21MP/E –Yield –
AngioDynamics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
AngioDynamics's revenue for the twelve months ending Aug 31, 2026 was $325.38M, up 8.2% year over year. For fiscal 2026 it was $320.17M, up 9.5% from the year before. Over ten years it grew -1.0% a year on average. The highest annual figure on record is $356.53M in fiscal 2015.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | May 31, 2026 | $320.17M | +9.5% |
| FY2025 | May 31, 2025 | $292.50M | -3.8% |
| FY2024 | May 31, 2024 | $303.91M | -10.3% |
| FY2023 | May 31, 2023 | $338.75M | +7.1% |
| FY2022 | May 31, 2022 | $316.22M | +8.7% |
| FY2021 | May 31, 2021 | $291.01M | +10.2% |
| FY2020 | May 31, 2020 | $264.16M | -2.4% |
| FY2019 | May 31, 2019 | $270.63M | +3.4% |
| FY2018 | May 31, 2018 | $261.66M | -3.0% |
| FY2017 | May 31, 2017 | $269.79M | -23.8% |
| FY2016 | May 31, 2016 | $353.89M | -0.7% |
| FY2015 | May 31, 2015 | $356.53M | +0.6% |
| FY2014 | May 31, 2014 | $354.43M | +3.7% |
| FY2013 | May 31, 2013 | $341.92M | +54.1% |
| FY2012 | May 31, 2012 | $221.92M | +2.9% |
| FY2011 | May 31, 2011 | $215.62M | -0.2% |
| FY2010 | May 31, 2010 | $216.04M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Aug 31, 2026 | $80.92M | +6.9% |
| Q4 FY2026CQ2 2026 | May 31, 2026 | $86.61M | +8.0% |
| Q3 FY2026CQ1 2026 | Feb 28, 2026 | $78.42M | +8.9% |
| Q2 FY2026CQ4 2025 | Nov 30, 2025 | $79.43M | +9.0% |
| Q1 FY2026CQ3 2025 | Aug 31, 2025 | $75.71M | +12.2% |
| Q4 FY2025CQ2 2025 | May 31, 2025 | $80.16M | +12.9% |
| Q3 FY2025CQ1 2025 | Feb 28, 2025 | $72.00M | -4.2% |
| Q2 FY2025CQ4 2024 | Nov 30, 2024 | $72.85M | -7.9% |
| Q1 FY2025CQ3 2024 | Aug 31, 2024 | $67.49M | -14.2% |
| Q4 FY2024CQ2 2024 | May 31, 2024 | $70.98M | -22.1% |
| Q3 FY2024CQ1 2024 | Feb 29, 2024 | $75.18M | -6.9% |
| Q2 FY2024CQ4 2023 | Nov 30, 2023 | $79.07M | -7.4% |
| Q1 FY2024CQ3 2023 | Aug 31, 2023 | $78.68M | -3.5% |
| Q4 FY2023CQ2 2023 | May 31, 2023 | $91.07M | +4.7% |
| Q3 FY2023CQ1 2023 | Feb 28, 2023 | $80.71M | +9.1% |
| Q2 FY2023CQ4 2022 | Nov 30, 2022 | $85.43M | +9.1% |
| Q1 FY2023CQ3 2022 | Aug 31, 2022 | $81.54M | +5.9% |
| Q4 FY2022CQ2 2022 | May 31, 2022 | $87.00M | +13.2% |
| Q3 FY2022CQ1 2022 | Feb 28, 2022 | $73.97M | +3.9% |
| Q2 FY2022CQ4 2021 | Nov 30, 2021 | $78.28M | +7.6% |
| Q1 FY2022CQ3 2021 | Aug 31, 2021 | $76.97M | +9.6% |
| Q4 FY2021CQ2 2021 | May 31, 2021 | $76.84M | +31.7% |
| Q3 FY2021CQ1 2021 | Feb 28, 2021 | $71.18M | +2.0% |
| Q2 FY2021CQ4 2020 | Nov 30, 2020 | $72.77M | +4.0% |
| Q1 FY2021CQ3 2020 | Aug 31, 2020 | $70.22M | +6.3% |
| Q4 FY2020CQ2 2020 | May 31, 2020 | $58.33M | -18.1% |
| Q3 FY2020CQ1 2020 | Feb 29, 2020 | $69.78M | +6.5% |
| Q2 FY2020CQ4 2019 | Nov 30, 2019 | $70.00M | +0.0% |
| Q1 FY2020CQ3 2019 | Aug 31, 2019 | $66.04M | +3.3% |
| Q4 FY2019CQ2 2019 | May 31, 2019 | $71.18M | +7.5% |
| Q3 FY2019CQ1 2019 | Feb 28, 2019 | $65.52M | +2.5% |
| Q2 FY2019CQ4 2018 | Nov 30, 2018 | $69.99M | +5.1% |
| Q1 FY2019CQ3 2018 | Aug 31, 2018 | $63.94M | -1.5% |
| Q4 FY2018CQ2 2018 | May 31, 2018 | $66.19M | -23.8% |
| Q3 FY2018CQ1 2018 | Feb 28, 2018 | $63.94M | -25.3% |
| Q2 FY2018CQ4 2017 | Nov 30, 2017 | $66.62M | -25.2% |
| Q1 FY2018CQ3 2017 | Aug 31, 2017 | $64.91M | – |
| Q4 FY2017CQ2 2017 | May 31, 2017 | $86.91M | – |
| Q3 FY2017CQ1 2017 | Feb 28, 2017 | $85.60M | – |
| Q2 FY2017CQ4 2016 | Nov 30, 2016 | $89.03M | – |
See a number that looks wrong?